Targretin bexarotene gel: Phase I data; marketed

LGND said data from a 9-patient U.S. Phase I trial showed Targretin may increase patient response

Read the full 168 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE